The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT07030998




Registration number
NCT07030998
Ethics application status
Date submitted
15/05/2025
Date registered
22/06/2025
Date last updated
2/07/2025

Titles & IDs
Public title
Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort
Scientific title
WEARABLES: Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort
Secondary ID [1] 0 0
111206
Universal Trial Number (UTN)
Trial acronym
WEARABLES
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Cancer 0 0
Infection 0 0
Digital Health 0 0
Wearable Devices 0 0
Condition category
Condition code
Infection 0 0 0 0
Studies of infection and infectious agents
Infection 0 0 0 0
Other infectious diseases

Intervention/exposure
Study type
Observational [Patient Registry]
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Treatment: Devices - Wearable Device

Treatment: Devices: Wearable Device
Wearable device to collect the following health metrics directly from participants for the duration of the study (4 weeks). Health metrics are collected every 15 minutes, except for the ECG which will be collected once per week.

Data points:

* ECG data (Once per week)
* Exercise time
* Body Temperature
* Heart Rate
* Irregular Heart Rhythm
* Blood Oxygen Saturation
* Respiratory Rate

Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Changes in cardiac electrical activity patterns on Electrocardiogram (ECG)
Timepoint [1] 0 0
Baseline (Day 1), Day 8, Day 15, Day 22, Day 29
Primary outcome [2] 0 0
Changes in physical activity
Timepoint [2] 0 0
Baseline (Day 1) and every 15 minutes until Study completion at Day 29
Primary outcome [3] 0 0
Changes in heart rate
Timepoint [3] 0 0
Baseline (Day 1) and every 15 minutes until Study completion at Day 29
Primary outcome [4] 0 0
Changes in heart rhythm
Timepoint [4] 0 0
Baseline (Day 1) and every 15 minutes until Study completion at Day 29
Primary outcome [5] 0 0
Changes in blood oxygen saturation
Timepoint [5] 0 0
Baseline (Day 1) and every 15 minutes until Study completion at Day 29
Primary outcome [6] 0 0
Changes in respiratory rate
Timepoint [6] 0 0
Baseline (Day 1) and every 15 minutes until Study completion at Day 29
Primary outcome [7] 0 0
Infection-Related Hospital Admission
Timepoint [7] 0 0
Baseline (Day 1), Day 8, Day 15, Day 22, Day 29
Secondary outcome [1] 0 0
The acceptability of using (and not using) wearable devices in children receiving cancer therapies
Timepoint [1] 0 0
Day 29

Eligibility
Key inclusion criteria
* Paediatric, adolescent or young adult diagnosis of cancer AND receiving therapy placing them at risk of infection
* Receiving cancer treatment at The Royal Children's Hospital
* Patients aged 5-18 years at time of the eligibility screening
* If aged < 16 years, parent or guardian able to provide consent
* iPhone 8 or later (iOS must be up to date/updated at time of enrolment)
* At least 10MB of iPhone storage for WEARABLES app and data collection.
* Willing and able to wear a wearable device for a period of 4 weeks (during waking hours).
* Consent to data being shared to the WEARABLES app (owned by the research team).
Minimum age
5 Years
Maximum age
18 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* <5 years of age.
* <16 years of age without guardian or parent consent.
* Aged 16-18 and unable to provide consent.
* Participant did not consent to wearing Apple Watch for a period of 4 weeks.

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
The Royal Children's Hospital - Parkville
Recruitment postcode(s) [1] 0 0
- Parkville

Funding & Sponsors
Primary sponsor type
Other
Name
Murdoch Childrens Research Institute
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Lane Collier
Address 0 0
Country 0 0
Phone 0 0
03 9936 6324
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?
The de-identified data set collected for this trial will be available 12 months after publication of the primary outcome.

The study protocol, analysis plan and consent forms will also be available. The data may be obtained from the Murdoch Children's Research Institute by emailing [email protected].

Supporting document/s available: Study protocol, Statistical analysis plan (SAP), Informed consent form (ICF)
When will data be available (start and end dates)?
The de-identified data set collected for this trial will be available 12 months after publication of the primary outcome. The data may be obtained from the Murdoch Children's Research Institute by emailing [email protected].

Prior to accessing any data, the following would be required: a data access agreement must be signed by all relevant parties, the investigators of the study must see and approve the analysis plan describing how the data will be analyzed. There must also be an agreement around appropriate acknowledgement in any future publications.
Available to whom?
The data may be obtained from the Murdoch Children's Research Institute by emailing [email protected].
Available for what types of analyses?
How or where can data be obtained?


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

No documents have been uploaded by study researchers.